Literature DB >> 29154878

Nanogel-based natural polymers as smart carriers for the controlled delivery of Timolol Maleate through the cornea for glaucoma.

Roya Ilka1, Mojdeh Mohseni2, Mehran Kianirad3, Masood Naseripour4, Khadijeh Ashtari5, Bita Mehravi6.   

Abstract

Despite frequent scientific efforts, efficient ocular drug delivery is a major challenge for pharmaceutical scientists. Poor bioavailability of ophthalmic solutions can be overcome by using smart ophthalmic drug-delivery systems. In this research, loading and delivery of Timolol Maleate (TM) through the cornea by synthesized nanoparticles based on biopolymers (chitosan-alginate) were studied. The physico-chemical properties of these nanoparticles were characterized using scanning electron microscopy (SEM), transmission electron microscopy (TEM) and dynamic light scattering (DLS). Loading and release were evaluated by a UV-vis spectrometer and the ex vivo permeation study was carried out using the Franz Diffusion Cell and fluorescent microscopy studies. The results indicated that morphology and size of nanoparticles were spherical and in the range of 80-100nm. The loading capacity and encapsulation efficiency were about 42% and 94% respectively. They illustrated a burst release in the first hour followed by a slower and more sustained drug release during the next 24h. Also, the results indicated that the cornea penetration of TM loaded in nanoparticles was twice than that of TM. Hence, this nanocarrier can be considered as a suitable candidate for controlled TM delivery and release through the cornea.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Glaucoma; Nanoparticles; Timolol maleate

Mesh:

Substances:

Year:  2017        PMID: 29154878     DOI: 10.1016/j.ijbiomac.2017.11.090

Source DB:  PubMed          Journal:  Int J Biol Macromol        ISSN: 0141-8130            Impact factor:   6.953


  6 in total

1.  Clarithromycin-Loaded Ocular Chitosan Nanoparticle: Formulation, Optimization, Characterization, Ocular Irritation, and Antimicrobial Activity.

Authors:  May Bin-Jumah; Sadaf Jamal Gilani; Mohammed Asadullah Jahangir; Ameeduzzafar Zafar; Sultan Alshehri; Mohd Yasir; Chandra Kala; Mohamad Taleuzzaman; Syed Sarim Imam
Journal:  Int J Nanomedicine       Date:  2020-10-13

Review 2.  Intravitreal Injectable Hydrogels for Sustained Drug Delivery in Glaucoma Treatment and Therapy.

Authors:  Kassahun Alula Akulo; Terin Adali; Mthabisi Talent George Moyo; Tulin Bodamyali
Journal:  Polymers (Basel)       Date:  2022-06-10       Impact factor: 4.967

3.  Sustained release glaucoma therapies: Novel modalities for overcoming key treatment barriers associated with topical medications.

Authors:  Aditya Belamkar; Alon Harris; Ryan Zukerman; Brent Siesky; Francesco Oddone; Alice Verticchio Vercellin; Thomas A Ciulla
Journal:  Ann Med       Date:  2022-12       Impact factor: 4.709

4.  Gelatin Nanoparticles-HPMC Hybrid System for Effective Ocular Topical Administration of Antihypertensive Agents.

Authors:  Sergio Esteban-Pérez; Vanessa Andrés-Guerrero; José Javier López-Cano; Irene Molina-Martínez; Rocio Herrero-Vanrell; Irene Bravo-Osuna
Journal:  Pharmaceutics       Date:  2020-03-28       Impact factor: 6.321

Review 5.  Nanotechnology for Medical and Surgical Glaucoma Therapy-A Review.

Authors:  Marcelo Luís Occhiutto; Raul C Maranhão; Vital Paulino Costa; Anastasios G Konstas
Journal:  Adv Ther       Date:  2019-12-10       Impact factor: 3.845

6.  Synergistic Effect of Acetazolamide-(2-hydroxy)propyl β-Cyclodextrin in Timolol Liposomes for Decreasing and Prolonging Intraocular Pressure Levels.

Authors:  Carmen M Arroyo-García; Daniela Quinteros; Santiago D Palma; Cesáreo J Jiménez de Los Santos; José R Moyano; Antonio M Rabasco; María Luisa González-Rodríguez
Journal:  Pharmaceutics       Date:  2021-11-25       Impact factor: 6.321

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.